⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

INCY

Incyte Corporation

Healthcare · Biotechnology

126.01USD

+1.6100 (+1.29%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 126.01
P/E17.6
Dvd Ind Yld—
P/B4.48
P/S4.7
Curr EV/T12M EBITDA12.1
Mkt Cap (USD)25.2B
Curr EV (USD)20.7B
2)

Per Share Data

EPS T12M7.11
DPS—
Bk Val Per Sh31.57
Rev/Sh25.92
Cash/Sh22.38
Curr Shares Out202.7M
FCF/Sh4.31
3)

Cash Flow Analysis

P/CF16.6
Curr P/FCF28.3
CF/NI1.1
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales28.3%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr4173.3%
Cap 1Y Gr49.9%
BPS 1Y Gr57.2%
R&D To Sales39.7%
Retention Rate100.0%
Rev 1Y Gr21.2%
FCF 1Y Gr56.9%
Assets 1Y Gr27.8%
5)

Profitability

EBITDA1.7B
EBIT1.6B
Operating Margin30.0%
Pretax Margin33.1%
Net Margin26.7%
ROA21.9%
ROE30.8%
ROC5.3%
Asset Turnover0.82
6)

Structure

Current Ratio3.68
Quick Ratio4.31
Debt/Assets259.0%
Debt/Com Eq338.1%
Net Debt/EBITDA9.12
Tot Debt/Capital77.2%
Gross Margin92.5%
EBIT/Int Exp689.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.